New drug tested for men with spreading prostate cancer
NCT ID NCT03843918
Summary
This early-stage trial tested a new drug called LAE001 for men with advanced prostate cancer that had spread and stopped responding to standard hormone therapy. The study aimed to find a safe dose and see if the drug could help control the cancer. All participants continued their standard hormone therapy while taking the new drug, and the trial was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan Cancer Hospital
Shanghai, Shanghai Municipality, China
-
ZheJiang Cancer Hospital
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.